PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26351778-7	2016	Interestingly, anti-CD47 antibody synergized the effect of HCC cells to chemotherapeutic drugs including doxorubicin and cisplatin.	Cisplatin	121-130	CD47 molecule	Homo sapiens	20-24	
20959404-1	2010	PURPOSE: Inhibitors of antiapoptosis protein (IAP) have been implicated in the resistance to cisplatin.	Cisplatin	93-102	CD47 molecule	Homo sapiens	9-44	
20959404-1	2010	PURPOSE: Inhibitors of antiapoptosis protein (IAP) have been implicated in the resistance to cisplatin.	Cisplatin	93-102	CD47 molecule	Homo sapiens	46-49	
33999416-0	2021	Anti-CD47 Antibody Synergizes with Cisplatin Against Laryngeal Cancer by Enhancing Phagocytic Ability of Macrophages.	Cisplatin	35-44	CD47 molecule	Homo sapiens	5-9	
33999416-5	2021	Cluster of Differentiation (CD47) was selected for its high expression in Cisplatin-treated laryngeal cancer cells.	Cisplatin	74-83	CD47 molecule	Homo sapiens	28-32	
33999416-6	2021	Blocking CD47 expression using its neutralizing antibody (aCD47) synergized with Cisplatin to increase macrophage phagocytosis in a co-culture system of human epithelial type 2 (Hep-2) cancer cells with tumor-associated macrophages (TAMs).	Cisplatin	81-90	CD47 molecule	Homo sapiens	9-13